Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results